Clouding of consciousness

Last updated

Clouding of consciousness, also called brain fog or mental fog, [1] [2] occurs when a person is slightly less wakeful or aware than normal. [3] They are less aware of time and their surroundings, and find it difficult to pay attention. [3] People describe this subjective sensation as their mind being "foggy". [4]

Contents

Background

The term clouding of consciousness has always denoted the main pathogenetic feature of delirium since physician Georg Greiner [5] pioneered the term (Verdunkelung des Bewusstseins) in 1817. [6] The Diagnostic and Statistical Manual of Mental Disorders (DSM) has historically used the term in its definition of delirium. [7] The DSM-III-R and the DSM-IV replaced "clouding of consciousness" with "disturbance of consciousness" to make it easier to operationalize, but it is still fundamentally the same thing. [8] Clouding of consciousness may be less severe than delirium on a spectrum of abnormal consciousness. [3] [9] [10] Clouding of consciousness may be synonymous with subsyndromal delirium. [11]

Subsyndromal delirium differs from normal delirium by being overall less severe, lacking acuteness in onset and duration, having a relatively stable sleep-wake cycle, and having relatively stable motor alterations. [12] Subsyndromal delirium's significant clinical features are inattention, thought process abnormalities, comprehension abnormalities, and language abnormalities. [12] Delirium's full clinical manifestations may never be reached. [11] Among intensive care unit patients, subsyndromal subjects were as likely to survive as patients with a Delirium Screening Checklist score of 0, but required extended care at rates greater than 0-scoring patients (although lower rates than those with full delirium) [11] or have a decreased post-discharge level of functional independence vs. the general population but still more independence than full delirium. [12]

In clinical practice, no standard test is exclusive and specific; therefore, the diagnosis depends on the physician's subjective impression. The DSM-IV-TR instructs clinicians to code subsyndromal delirium presentations under the miscellaneous category "cognitive disorder not otherwise specified". [13]

Psychopathology

The conceptual model of clouding of consciousness is that of a part of the brain regulating the "overall level" of consciousness, which is responsible for awareness of oneself and of the environment. [3] [14] Various etiologies disturb this regulating part of the brain, which in turn disturbs the "overall level" of consciousness. [15] This system of a sort of general activation of consciousness is called "arousal" or "wakefulness". [14]

It is not necessarily accompanied by drowsiness. [16] Patients may be awake (not sleepy) yet still have a clouded consciousness (disorder of wakefulness). [17] Paradoxically, affected individuals say that they are "awake but, in another way, not". [18] Lipowski points out that decreased "wakefulness" as used here is not exactly synonymous with drowsiness. One is a stage on the way to coma, the other on the way to sleep, which is very different. [19] [20]

The affected person has a sensation of mental clouding described in the patient's own words as "foggy". [4] One patient said, "I thought it became like misty, in some way... the outlines were sort of fuzzy". [18] Others may describe a "spaced-out" feeling. [21] Affected people compare their overall experience to that of a dream, because, as in a dream, consciousness, attention, orientation to time and place, perceptions, and awareness are disturbed. [22] Barbara Schildkrout, a clinical instructor in psychiatry at the Harvard Medical School, described her subjective experience of clouding of consciousness, which she also called "mental fog", after taking a single dose of chlorpheniramine (an antihistamine for her allergy to cottonwood) on a cross-country road trip. She described feeling "out of it" and being in a "dreamy state". She described a sense of not trusting her own judgment and a dulled awareness, not knowing how much time had passed. [1] Clouding of consciousness is not the same thing as depersonalization , though people affected by both compare their experience to that of a dream. Psychometric tests produce little evidence of a relationship between clouding of consciousness and depersonalization. [23]

Brain fog may affect performance on virtually any cognitive task. [1] As one author put it, "It should be apparent that cognition is not possible without a reasonable degree of arousal." [3] Cognition includes perception, memory, learning, executive functions, language, constructive abilities, voluntary motor control, attention, and mental speed. Brain fog's most significant clinical features are inattention, thought process abnormalities, comprehension abnormalities, and language abnormalities. [12] The extent of the impairment is variable because inattention may impair several cognitive functions. Affected people may complain of forgetfulness, being "confused", [24] or being "unable to think straight". [24] Despite the similarities, subsyndromal delirium is not the same thing as mild cognitive impairment ; the fundamental difference is that mild cognitive impairment is a dementia-like impairment, which does not involve a disturbance in arousal (wakefulness). [25]

In diseases

The term "brain fog" is used to represent a subjective condition of perceived cognitive impairment. It is defined as "a phenomenon of fluctuating states of perceived cognitive dysfunction that could have implications in the functional application of cognitive skills in people's participation in daily activities". [26] Brain fog is a common symptom in many illnesses where chronic pain is a major component. [26] Brain fog affects 15% to 40% of those with chronic pain as their major illness. [27] In such illnesses, pain processing may use up resources, decreasing the brain's ability to think effectively. [26]

Many people with fibromyalgia experience cognitive problems [28] (known as "fibrofog" or "brainfog"), which may involve impaired concentration, [29] [30] [ unreliable medical source? ] [31] problems with short [32] - and long-term memory, short-term memory consolidation, [32] working memory, [33] impaired speed of performance, [32] inability to multitask, cognitive overload, [32] and diminished attention span. About 75% of fibromyalgia patients report significant problems with concentration, memory, and multitasking. [34] A 2018 meta-analysis found that the largest differences between fibromyalgia patients and healthy subjects were for inhibitory control, memory, and processing speed. [34] Many of these are also common symptoms of ADHD (attention deficit hyperactivity disorder), and studies have linked the two conditions, to the point that a fibromyalgia diagnosis has been proposed as an indication to screen for ADHD. [35] [36] [37] It is alternatively hypothesized that the increased pain compromises attention systems, resulting in cognitive problems. [34]

In chronic fatigue syndrome, also known as myalgic encephalomyelitis, the CDC's recommended criteria for diagnosis [38] include that one of the following symptoms must be present: [38]

Lyme disease's neurologic syndrome, called Lyme encephalopathy, is associated with subtle memory and cognitive difficulties, among other issues. [39] Lyme can cause a chronic encephalomyelitis that resembles multiple sclerosis. It may be progressive and can involve cognitive impairment, migraines, balance problems, and other symptoms.[ citation needed ]

Brain fog is a common symptom of hypothyroidism, with a survey showing that 79.2% of those with the condition reported experiencing brain fog to some extent, either selecting the option for "frequently" or "all the time". [40] While it is unclear how the disease leads to brain fog, proper treatment with levothyroxine has been shown to reduce cognitive impairment. [41]

The emerging concept of sluggish cognitive tempo has also been implicated in the expression of brain fog symptoms. [42]

Patients recovering from COVID-19 report experiencing brain fog, which can reflect a wide variety of neurological and psychological symptoms linked to COVID-19. [43]

Brain fog and other neurological symptoms may also result from mold exposure. [44] [45] [46] [47] [48] This may be due to mycotoxin exposure and consequent innate immune system activation and inflammation, including in the central nervous system. [49] [44] [45] [46] [47] [48] But adverse neurological health effects of mold exposure are controversial due to inadequate research and data, and more research is needed in this area. [49] [50] [51] [44] [46] [48]

See also

Related Research Articles

<span class="mw-page-title-main">Catatonia</span> Psychiatric behavioural syndrome

Catatonia is a complex syndrome, most commonly seen in people with underlying mood or psychotic disorders. People with catatonia have abnormal movement and behaviors, which vary from person to person and fluctuate in intensity within a single episode. People with catatonia appear withdrawn, meaning that they do not interact with the outside world and have difficulty processing information. They may be nearly motionless for days on end or perform repetitive purposeless movements. Two people may exhibit very different sets of behaviors and both still be diagnosed with catatonia. Treatment with benzodiazepines or ECT are most effective and lead to remission of symptoms in most cases.

Delirium is a specific state of acute confusion attributable to the direct physiological consequence of a medical condition, effects of a psychoactive substance, or multiple causes, which usually develops over the course of hours to days. As a syndrome, delirium presents with disturbances in attention, awareness, and higher-order cognition. People with delirium may experience other neuropsychiatric disturbances including changes in psychomotor activity, disrupted sleep-wake cycle, emotional disturbances, disturbances of consciousness, or, altered state of consciousness, as well as perceptual disturbances, although these features are not required for diagnosis.

A vegetative state (VS) or post-coma unresponsiveness (PCU) is a disorder of consciousness in which patients with severe brain damage are in a state of partial arousal rather than true awareness. After four weeks in a vegetative state, the patient is classified as being in a persistent vegetative state (PVS). This diagnosis is classified as a permanent vegetative state some months after a non-traumatic brain injury or one year after a traumatic injury. The term unresponsive wakefulness syndrome may be used alternatively, as "vegetative state" has some negative connotations among the public.

<span class="mw-page-title-main">Fibromyalgia</span> Chronic pain of unknown cause

Fibromyalgia is a medical syndrome that causes chronic widespread pain, accompanied by fatigue, awakening unrefreshed, and cognitive symptoms. Other symptoms can include headaches, lower abdominal pain or cramps, and depression. People with fibromyalgia can also experience insomnia and general hypersensitivity. The cause of fibromyalgia is unknown, but is believed to involve a combination of genetic and environmental factors. Environmental factors may include psychological stress, trauma, and some infections. Since the pain appears to result from processes in the central nervous system, the condition is referred to as a "central sensitization syndrome". Although a protocol using an algometer (algesiometer) for determining central sensitization has been proposed as an objective diagnostic test, fibromyalgia continues to be primarily diagnosed by exclusion despite the high possibility of misdiagnosis.

Hypersomnia is a neurological disorder of excessive time spent sleeping or excessive sleepiness. It can have many possible causes and can cause distress and problems with functioning. In the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), hypersomnolence, of which there are several subtypes, appears under sleep-wake disorders.

<span class="mw-page-title-main">Conditions comorbid to autism</span> Medical conditions more common in autistic people

Autism spectrum disorder (ASD) is a neurodevelopmental disorder that begins in early childhood, persists throughout adulthood, and is characterized by difficulties in social communication and restricted, repetitive patterns of behavior. There are many conditions comorbid to autism spectrum disorder, such as attention deficit hyperactivity disorder, anxiety disorders, and epilepsy.

Ganser syndrome is a rare dissociative disorder characterized by nonsensical or wrong answers to questions and other dissociative symptoms such as fugue, amnesia or conversion disorder, often with visual pseudohallucinations and a decreased state of consciousness. The syndrome has also been called nonsense syndrome, balderdash syndrome, syndrome of approximate answers, hysterical pseudodementia or prison psychosis.

Cognitive disorders (CDs), also known as neurocognitive disorders (NCDs), are a category of mental health disorders that primarily affect cognitive abilities including learning, memory, perception, and problem-solving. Neurocognitive disorders include delirium, mild neurocognitive disorders, and major neurocognitive disorder. They are defined by deficits in cognitive ability that are acquired, typically represent decline, and may have an underlying brain pathology. The DSM-5 defines six key domains of cognitive function: executive function, learning and memory, perceptual-motor function, language, complex attention, and social cognition.

Cognitive disengagement syndrome (CDS) is a syndrome characterized by developmentally inappropriate, impairing, and persistent levels of decoupled attentional processing from the ongoing external context and resultant hypoactivity. Symptoms often manifest in difficulties with staring, mind blanking, absent-mindedness, mental confusion and maladaptive mind-wandering alongside delayed, sedentary or slow motor movements. To scientists in the field, it has reached the threshold of evidence and recognition as a distinct syndrome.

Post-concussion syndrome (PCS), also known as persisting symptoms after concussion, is a set of symptoms that may continue for weeks, months, or years after a concussion. PCS is medically classified as a mild traumatic brain injury (TBI). About 35% of people with concussion experience persistent or prolonged symptoms 3 to 6 months after injury. Prolonged concussion is defined as having concussion symptoms for over four weeks following the first accident in youth and for weeks or months in adults.

<span class="mw-page-title-main">Frontal lobe disorder</span> Brain disorder

Frontal lobe disorder, also frontal lobe syndrome, is an impairment of the frontal lobe of the brain due to disease or frontal lobe injury. The frontal lobe plays a key role in executive functions such as motivation, planning, social behaviour, and speech production. Frontal lobe syndrome can be caused by a range of conditions including head trauma, tumours, neurodegenerative diseases, neurodevelopmental disorders, neurosurgery and cerebrovascular disease. Frontal lobe impairment can be detected by recognition of typical signs and symptoms, use of simple screening tests, and specialist neurological testing.

<span class="mw-page-title-main">Organic brain syndrome</span> Disorder of mental function whose cause is alleged to be known as physiological

Organic brain syndrome, also known as organic brain disease, organic brain damage, organic brain disorder (OBD), organic mental syndrome, or organic mental disorder, refers to any syndrome or disorder of mental function whose cause is alleged to be known as organic (physiologic) rather than purely of the mind. These names are older and nearly obsolete general terms from psychiatry, referring to many physical disorders that cause impaired mental function. They are meant to exclude psychiatric disorders. Originally, the term was created to distinguish physical causes of mental impairment from psychiatric disorders, but during the era when this distinction was drawn, not enough was known about brain science for this cause-based classification to be more than educated guesswork labeled with misplaced certainty, which is why it has been deemphasized in current medicine. While mental or behavioural abnormalities related to the dysfunction can be permanent, treating the disease early may prevent permanent damage in addition to fully restoring mental functions. An organic cause to brain dysfunction is suspected when there is no indication of a clearly defined psychiatric or "inorganic" cause, such as a mood disorder.

Medically unexplained physical symptoms are symptoms for which a treating physician or other healthcare providers have found no medical cause, or whose cause remains contested. In its strictest sense, the term simply means that the cause for the symptoms is unknown or disputed—there is no scientific consensus. Not all medically unexplained symptoms are influenced by identifiable psychological factors. However, in practice, most physicians and authors who use the term consider that the symptoms most likely arise from psychological causes. Typically, the possibility that MUPS are caused by prescription drugs or other drugs is ignored. It is estimated that between 15% and 30% of all primary care consultations are for medically unexplained symptoms. A large Canadian community survey revealed that the most common medically unexplained symptoms are musculoskeletal pain, ear, nose, and throat symptoms, abdominal pain and gastrointestinal symptoms, fatigue, and dizziness. The term MUPS can also be used to refer to syndromes whose etiology remains contested, including chronic fatigue syndrome, fibromyalgia, multiple chemical sensitivity and Gulf War illness.

Oneiroid syndrome (OS) is a condition involving dream-like disturbances of one's consciousness by vivid scenic hallucinations, accompanied by catatonic symptoms (either catatonic stupor or excitement), delusions, or psychopathological experiences of a kaleidoscopic nature. The term is from Ancient Greek "ὄνειρος" (óneiros, meaning "dream") and "εἶδος" (eîdos, meaning "form, likeness"; literally dream-like / oneiric or oniric, sometimes called "nightmare-like"). It is a common complication of catatonic schizophrenia, although it can also be caused by other mental disorders. The dream-like experiences are vivid enough to seem real to the patient. OS is distinguished from delirium by the fact that the imaginative experiences of patients always have an internal projection. This syndrome is hardly mentioned in standard psychiatric textbooks, possibly because it is not listed in DSM.

Pseudodementia is a condition that leads to cognitive and functional impairment imitating dementia that is secondary to psychiatric disorders, especially depression. Pseudodementia can develop in a wide range of neuropsychiatric disease such as depression, schizophrenia and other psychosis, mania, dissociative disorders, and conversion disorders. The presentations of pseudodementia may mimic organic dementia, but are essentially reversible on treatment and doesn't lead to actual brain degeneration. However, it has been found that some of the cognitive symptoms associated with pseudodementia can persist as residual symptoms and even transform into true neurodegenerative dementia in some cases.

<span class="mw-page-title-main">Alcohol withdrawal syndrome</span> Medical condition

Alcohol withdrawal syndrome (AWS) is a set of symptoms that can occur following a reduction in alcohol use after a period of excessive use. Symptoms typically include anxiety, shakiness, sweating, vomiting, fast heart rate, and a mild fever. More severe symptoms may include seizures, and delirium tremens (DTs); which can be fatal in untreated patients. Symptoms start at around 6 hours after last drink. Peak incidence of seizures occurs at 24-36 hours and peak incidence of delirium tremens is at 48-72 hours.

<span class="mw-page-title-main">Neurological disorder</span> Any disorder of the nervous system

Neurological disorders represent a complex array of medical conditions that fundamentally disrupt the functioning of the nervous system. These disorders affect the brain, spinal cord, and nerve networks, presenting unique diagnosis, treatment, and patient care challenges. At their core, they represent disruptions to the intricate communication systems within the nervous system, stemming from genetic predispositions, environmental factors, infections, structural abnormalities, or degenerative processes.

Functional disorders are a group of recognisable medical conditions which are due to changes to the functioning of the systems of the body rather than due to a disease affecting the structure of the body.

Somatic symptom disorder, also known as somatoform disorder or somatization disorder, is defined by one or more chronic physical symptoms that coincide with excessive and maladaptive thoughts, emotions, and behaviors connected to those symptoms. The symptoms are not deliberately produced or feigned, and they may or may not coexist with a known medical ailment.

Functional somatic syndrome (FSS) is any of a group of chronic diagnoses with no identifiable organic cause. This term was coined by Hemanth Samkumar. It encompasses disorders such as fibromyalgia, chronic widespread pain, temporomandibular disorder, irritable bowel syndrome, lower back pain, tension headache, atypical face pain, non-cardiac chest pain, insomnia, palpitation, dyspepsia and dizziness. General overlap exists between this term, somatization and somatoform. The status of ME/CFS as a functional somatic syndrome is contested. Although the aetiology remains unclear, there are consistent findings of biological abnormalities, and major health bodies such as the NAM, WHO, and NIH, classify it as an organic disease.

References

  1. 1 2 3 Schildkrout, Barbara (2011). Unmasking Psychological Symptoms. John Wiley & Sons. pp. 183–184. ISBN   978-0470639078.
  2. ↑ Basavanna, M. (2000). Dictionary of Psychology. Allied Publishers. p. 65. ISBN   8177640305.
  3. 1 2 3 4 5 Plum and Posner's diagnosis of stupor and coma. Oxford University Press. 2007. pp. 5–6. ISBN   978-0199886531.
  4. 1 2 Augusto Caraceni; Luigi Grassi (2011). Delirium: Acute Confusional States in Palliative Medicine. Oxford University Press. p. 82. ISBN   978-0199572052.
  5. ↑ Georg Friedrich Christoph Greiner (1817). Der Traum und das fieberhafte Irreseyn: ein physiologisch-psychologischer Versuch. F. A Brockhaus. OCLC   695736431.
  6. ↑ Augusto Caraceni; Luigi Grassi (2011). Delirium: Acute Confusional States in Palliative Medicine. Oxford University Press. p. 2. ISBN   978-0199572052.
  7. ↑ George Stein; Greg Wilkinson (2007). Seminars in General Adult Psychiatry. RCPsych Publications. p. 490. ISBN   978-1904671442.
  8. ↑ Dan G. Blazer; Adrienne O. van Nieuwenhuizen (2012). "Evidence for the Diagnostic Criteria of Delirium". Curr Opin Psychiatry. 25 (3): 239–243. doi:10.1097/yco.0b013e3283523ce8. PMID   22449764. S2CID   39516431.
  9. ↑ Anthony David; Simon Fleminger; Michael Kopelman; Simon Lovestone; John Mellers (April 2012). Lishman's Organic Psychiatry: A Textbook of Neuropsychiatry. John Wiley & Sons. p. 5. ISBN   978-0470675076.
  10. ↑ Fang Gao Smith (2010). Core Topics in Critical Care Medicine. Cambridge University Press. p. 312. ISBN   978-1139489683.
  11. 1 2 3 Sébastien Ouimet; Riker, R; Bergeron, N; Cossette, M; Kavanagh, B; Skrobik, Y; et al. (2007). "Subsyndromal delirium in the ICU: evidence for a disease spectrum". Intensive Care Med. 33 (6): 1007–1013. doi:10.1007/s00134-007-0618-y. PMID   17404704. S2CID   20565946.
  12. 1 2 3 4 David Meagher; Adamis, D.; Trzepacz, P.; Leonard, M.; et al. (2012). "Features of subsyndromal and persistent delirium". The British Journal of Psychiatry. 200 (1): 37–44. doi: 10.1192/bjp.bp.111.095273 . PMID   22075650.
  13. ↑ Augusto Caraceni; Luigi Grassi (2011). Delirium: Acute Confusional States in Palliative Medicine. Oxford University Press. p. 11. ISBN   978-0199572052.
  14. 1 2 Augusto Caraceni; Luigi Grassi (2011). Delirium: Acute Confusional States in Palliative Medicine. Oxford University Press. pp. 19–21. ISBN   978-0199572052.
  15. ↑ Yudofsky & Hales (2008). The American Psychiatric Publishing textbook of neuropsychiatry and behavioral neurosciences. American Psychiatric Pub. p. 477. ISBN   978-1585622399.
  16. ↑ Roger A. MacKinnon; Robert Michels; Peter J. Buckley (2006). The Psychiatric Interview in Clinical Practice (2nd ed.). American Psychiatric Publishing, Inc. pp. 462–464.
  17. ↑ Plum and Posner's diagnosis of stupor and coma. Oxford University Press. 2007. p. 8. ISBN   978-0198043362.
  18. 1 2 G Sorensen Duppils; K Wikblad (May 2007). "Patients' experiences of being delirious". Journal of Clinical Nursing. 16 (5): 810–818. doi:10.1111/j.1365-2702.2006.01806.x. PMID   17462032.
  19. ↑ Lipowski ZJ. (1967). "Delirium, clouding of consciousness and confusion". Journal of Nervous and Mental Disease. 145 (3): 227–255. doi:10.1097/00005053-196709000-00006. PMID   4863989.
  20. ↑ William Alwyn Lishman (1998). Organic Psychiatry: The Psychological Consequences of Cerebral Disorder. John Wiley & Sons. p. 4.
  21. ↑ Fred Ovsiew, M.D. (1999). Neuropsychiatry and Mental Health Services. American Psychiatric Press, Inc. p. 170. ISBN   0880487305.
  22. ↑ Simon Fleminger (2002). "Remembering delirium". The British Journal of Psychiatry. 180 (1): 4–5. doi: 10.1192/bjp.180.1.4 . PMID   11772842.
  23. ↑ Sedman, G. (July 1970). "Theories of Depersonalization: A Re-appraisal". British Journal of Psychiatry. 117 (536): 1–14. doi:10.1192/s0007125000192104. PMID   4920886. S2CID   246610704.
  24. 1 2 John Noble; Harry L. Greene (1996). Textbook of Primary Care Medicine. Mosby. p. 1325.
  25. ↑ Plum and Posner's diagnosis of stupor and coma. Oxford University Press. 2007. p. 7. ISBN   978-0199886531.
  26. 1 2 3 Dass, Ronessa; Kalia, Mohini; Harris, Jocelyn; Packham, Tara (2023-12-31). "Understanding the Experience and Impacts of Brain Fog in Chronic Pain: A Scoping Review". Canadian Journal of Pain. 7 (1). doi:10.1080/24740527.2023.2217865. ISSN   2474-0527. PMC   10334862 . PMID   37441085.
  27. ↑ Kucyi, Aaron; Davis, Karen D. (2015). "The dynamic pain connectome". Trends in Neurosciences. 38 (2): 86–95. doi:10.1016/j.tins.2014.11.006. PMID   25541287. S2CID   745129.
  28. ↑ Glass, Jennifer M. (November 2006). "Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: New trends and future directions". Current Rheumatology Reports. 8 (6): 425–429. doi:10.1007/s11926-006-0036-0. PMID   17092441. S2CID   27103590.
  29. ↑ Arnold, Lesley M.; Bennett, Robert M.; Crofford, Leslie J.; Dean, Linda E.; Clauw, Daniel J.; Goldenberg, Don L.; Fitzcharles, Mary-Ann; Paiva, Eduardo S.; Staud, Roland; Sarzi-Puttini, Piercarlo; Buskila, Dan; Macfarlane, Gary J. (June 2019). "AAPT Diagnostic Criteria for Fibromyalgia". The Journal of Pain. 20 (6): 611–628. doi: 10.1016/j.jpain.2018.10.008 . hdl: 2434/632765 . PMID   30453109. S2CID   53872511.
  30. ↑ Williams, David A; Clauw, Daniel J; Glass, Jennifer M (April 2011). "Perceived Cognitive Dysfunction in Fibromyalgia Syndrome". Journal of Musculoskeletal Pain. 19 (2): 66–75. doi:10.3109/10582452.2011.558989. S2CID   144893303.
  31. ↑ [ unreliable medical source? ]Leavitt, Frank; Katz, Robert S.; Mills, Megan; Heard, Amy R. (April 2002). "Cognitive and Dissociative Manifestations in Fibromyalgia". JCR: Journal of Clinical Rheumatology. 8 (2): 77–84. doi:10.1097/00124743-200204000-00003. PMID   17041327. S2CID   12352666.
  32. 1 2 3 4 Buskila, Dan; Cohen, Hagit (October 2007). "Comorbidity of fibromyalgia and psychiatric disorders". Current Pain and Headache Reports. 11 (5): 333–338. doi:10.1007/s11916-007-0214-4. PMID   17894922. S2CID   28038437.
  33. ↑ Mercado, Francisco; Ferrera, David; Fernandes-Magalhaes, Roberto; Peláez, Irene; Barjola, Paloma (2 March 2022). "Altered Subprocesses of Working Memory in Patients with Fibromyalgia: An Event-Related Potential Study Using N -Back Task". Pain Medicine. 23 (3): 475–487. doi:10.1093/pm/pnab190. PMID   34145889.
  34. 1 2 3 Bell, Tyler; Trost, Zina; Buelow, Melissa T.; Clay, Olivio; Younger, Jarred; Moore, David; Crowe, Michael (9 August 2018). "Meta-analysis of cognitive performance in fibromyalgia". Journal of Clinical and Experimental Neuropsychology. 40 (7): 698–714. doi:10.1080/13803395.2017.1422699. PMC   6151134 . PMID   29388512.
  35. ↑ Bou Khalil, Rami; Khoury, Elie; Richa, Sami (1 September 2018). "The Comorbidity of Fibromyalgia Syndrome and Attention Deficit and Hyperactivity Disorder from a Pathogenic Perspective". Pain Medicine. 19 (9): 1705–1709. doi: 10.1093/pm/pny142 . PMID   30053155.
  36. ↑ Yilmaz, Ertan; Tamam, Lut (24 July 2018). "Attention-deficit hyperactivity disorder and impulsivity in female patients with fibromyalgia". Neuropsychiatric Disease and Treatment. 14: 1883–1889. doi: 10.2147/NDT.S159312 . PMC   6063452 . PMID   30100723.
  37. ↑ "Study Suggests Screening Patients with Fibromyalgia Syndrome for ADHD". 28 December 2017.
  38. 1 2 "Symptoms of ME/CFS | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". CDC. 9 February 2021.
  39. ↑ Bratton, Robert L.; Whiteside, John W.; Hovan, Michael J.; Engle, Richard L.; Edwards, Frederick D. (May 2008). "Diagnosis and Treatment of Lyme Disease". Mayo Clinic Proceedings. 83 (5): 566–571. doi: 10.4065/83.5.566 . PMID   18452688.
  40. ↑ Ettleson, Matthew D.; Raine, Ava; Batistuzzo, Alice; Batista, Samuel P.; McAninch, Elizabeth; Teixeira, Maria Cristina T.V.; Jonklaas, Jacqueline; Laiteerapong, Neda; Ribeiro, Miriam O.; Bianco, Antonio C. (March 2022). "Brain Fog in Hypothyroidism: Understanding the Patient's Perspective". Endocrine Practice. 28 (3): 257–264. doi:10.1016/j.eprac.2021.12.003. PMC   8901556 . PMID   34890786.
  41. ↑ Smith, Jeremy W.; Evans, A Tudor; Costall, B; Smythe, James W. (January 2002). "Thyroid hormones, brain function and cognition: a brief review". Neuroscience & Biobehavioral Reviews. 26 (1): 045–60. doi:10.1016/s0149-7634(01)00037-9. PMID   11835983.
  42. ↑ Barkley, Russell A. (2013). Taking Charge of ADHD: The Complete, Authoritative Guide for Parents. Guilford Publications. p. 150. ISBN   978-1-4625-0789-4.
  43. ↑ Koralnik, Igor J.; Tyler, Kenneth L. (July 2020). "COVID-19: A Global Threat to the Nervous System". Annals of Neurology. 88 (1): 1–11. doi:10.1002/ana.25807. PMC   7300753 . PMID   32506549.
  44. 1 2 3 Empting LD (2009). "Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure". Toxicol Ind Health. 25 (9–10): 577–581. Bibcode:2009ToxIH..25..577E. doi:10.1177/0748233709348393. PMID   19854819. S2CID   27769836.
  45. 1 2 Valtonen V (2017). "Clinical Diagnosis of the Dampness and Mold Hypersensitivity Syndrome: Review of the Literature and Suggested Diagnostic Criteria". Front Immunol. 8: 951. doi: 10.3389/fimmu.2017.00951 . PMC   5554125 . PMID   28848553.
  46. 1 2 3 Harding CF, Liao D, Persaud R, DeStefano RA, Page KG, Stalbow LL, Roa T, Ford JC, Goman KD, Pytte CL (March 2023). "Differential effects of exposure to toxic or nontoxic mold spores on brain inflammation and Morris water maze performance". Behav Brain Res. 442: 114294. doi:10.1016/j.bbr.2023.114294. PMC   10460635 . PMID   36638914.
  47. 1 2 Ratnaseelan AM, Tsilioni I, Theoharides TC (June 2018). "Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes". Clin Ther. 40 (6): 903–917. doi: 10.1016/j.clinthera.2018.05.004 . PMID   29880330.
  48. 1 2 3 Harding CF, Pytte CL, Page KG, Ryberg KJ, Normand E, Remigio GJ, DeStefano RA, Morris DB, Voronina J, Lopez A, Stalbow LA, Williams EP, Abreu N (July 2020). "Mold inhalation causes innate immune activation, neural, cognitive and emotional dysfunction". Brain Behav Immun. 87: 218–228. doi:10.1016/j.bbi.2019.11.006. PMC   7231651 . PMID   31751617.
  49. 1 2 Viljoen, Margaretha; Claassen, Nicolaas (February 2023). "Pathophysiological aspects of exposure to dampness-associated indoor mould and mycotoxins: A mini-overview". Journal of Hazardous Materials Advances. 9: 100228. Bibcode:2023JHzMA...900228V. doi: 10.1016/j.hazadv.2022.100228 . hdl: 2263/95331 . ISSN   2772-4166.
  50. ↑ Rudert A, Portnoy J (August 2017). "Mold allergy: is it real and what do we do about it?". Expert Rev Clin Immunol. 13 (8): 823–835. doi:10.1080/1744666X.2017.1324298. PMID   28453304. S2CID   4755858.
  51. ↑ Borchers AT, Chang C, Eric Gershwin M (June 2017). "Mold and Human Health: a Reality Check". Clin Rev Allergy Immunol. 52 (3): 305–322. doi:10.1007/s12016-017-8601-z. PMID   28299723. S2CID   25709697.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.